Literature DB >> 10651290

Protists as opportunistic pathogens: public health impact in the 1990s and beyond.

J E Kaplan1, J L Jones, C A Dykewicz.   

Abstract

Protist organisms (protozoa and fungi) have become increasingly prominent as opportunistic pathogens among persons infected with human immunodeficiency virus (HIV) and among organ transplant recipients--two immunocompromised populations that have increased dramatically in the past two decades. Pneumocystis carinii pneumonia continues to be the most common serious opportunistic infection (OI) among HIV-infected persons in the United States, occurring frequently among persons not previously receiving medical care. Toxoplasmosis, cryptococcosis, cryptosporidiosis, and isosporiasis occur frequently in HIV-infected persons in the developing world. Candidiasis and aspergillosis are common OIs in organ transplant recipients. As these populations of immunosuppressed patients continue to expand worldwide new OIs caused by protist pathogens are likely to emerge.

Entities:  

Mesh:

Year:  2000        PMID: 10651290     DOI: 10.1111/j.1550-7408.2000.tb00004.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  6 in total

Review 1.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Whole-genome analysis reveals molecular innovations and evolutionary transitions in chromalveolate species.

Authors:  Cindy Martens; Klaas Vandepoele; Yves Van de Peer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

3.  Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.

Authors:  Comfort A Boateng; Suresh V K Eyunni; Xue Y Zhu; Jagan R Etukala; Barbara A Bricker; M K Ashfaq; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2010-11-10       Impact factor: 3.641

4.  Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions.

Authors:  Laura Wegener Parfrey; William A Walters; Rob Knight
Journal:  Front Microbiol       Date:  2011-07-11       Impact factor: 5.640

5.  Comparative genome analysis reveals a conserved family of actin-like proteins in apicomplexan parasites.

Authors:  Jennifer L Gordon; L David Sibley
Journal:  BMC Genomics       Date:  2005-12-12       Impact factor: 3.969

Review 6.  Contrasting Strategies: Human Eukaryotic Versus Bacterial Microbiome Research.

Authors:  Katarzyna B Hooks; Maureen A O'Malley
Journal:  J Eukaryot Microbiol       Date:  2019-10-20       Impact factor: 3.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.